Effects of probenecid on the migration and proliferation ability of platelet derived growth factor-BB induced pulmonary artery smooth muscle cells in rats

doi:10.12047/j.cjap.6326.2022.101

Abstract

Abstract: Objective: To investigate whether probenecid (PROB) could improve the proliferation and migration ability of rats' pulmonary artery smooth muscle cells induced by platelet-derived growth factor-BB (PDGF-BB). Methods: Primary pulmonary artery smooth muscle cells (PASMCs) of SD rats were cultured in vitro, and were randomly divided into control group (CON group), PDGF-BB group (10 ng/ml PDGF-BB treatment for 24 h) and PDGF-BB+PROB group (10 ng/ml PDGF-BB and 200 μmol/L PROB treatment for 24 h, PROB is a specific blocker of pannexin-1). CCK-8 method was used to select the suitable intervention concentrations of PROB and PDGF-BB, and to detect the proliferation of PASMCs in each group. The migration ability of PASMCs was detected by Transwell^TM assay and cell scratch test. Immunofluorescence cytochemistry and Western blot were used to detect the protein expressions and distribution of osteopontin (OPN) and proliferating cell nuclear antigen (PCNA) in PASMCs. Results: Compared with CON group, the migration and proliferation ability of PASMCs in PDGF-BB group were enhanced (P＜0.05). After treated with PROB, the migration and proliferation ability of PASMCs in PDGF-BB+PROB group were decreased significantly (P＜0.05). Compared with CON group, the expression and protein levels of OPN and PCNA in PDGF-BB group were increased significantly (P＜0.05), while the expression and protein levels of OPN and PCNA in PDGF-BB+PROB were decreased significantly (P＜0.05). Conclusion: Probenecid inhibits the migration and proliferation of PDGF-BB-induced PASMCs by blocking Pannexin-1.

Key words: probenecid, pannexin-1, PASMCs, migration, proliferation

CLC Number:

R543.2
R965

NIGALA Aikeremu, GAO Rui-juan, TANG Xue-chun, KONG Liang-jing-yuan, GAO Yi-xuan, YUAN Jia-yue, MA ke-tao, LI Li, SI Jun-qiang. Effects of probenecid on the migration and proliferation ability of platelet derived growth factor-BB induced pulmonary artery smooth muscle cells in rats[J]. CJAP, 2022, 38(5): 543-548.

References

[1] Montani D, Günther S, Dorfmüller P, et al. Pulmonary arterial hypertension[J]. Orphanet J Rare Dis, 2013, 8: 97.
[2] Hassoun PM. Pulmonary arterial hypertension[J]. N Engl J Med, 2021, 385(25): 2361-2376.
[3] Worssam MD, Jørgensen HF. Mechanisms of vascular smooth muscle cell investment and phenotypic diversification in vascular diseases[J]. Biochem Soc Trans, 2021, 49(5): 2101-2111.
[4] Scemes E, Velíšková J. Exciting and not so exciting roles of pannexins[J]. Neurosci Lett, 2019, 695(16): 25-31.
[5] Lohman AW, Billaud M, Straub AC, et al. Expression of pannexin isoforms in the systemic murine arterial network[J]. J Vasc Res, 2012, 49(5): 405-416.
[6] Good ME, Begandt D, DeLalio LJ, et al. Emerging concepts regarding pannexin 1 in the vasculature[J]. Biochem Soc T, 2015, 43(3): 495-501.
[7] Billaud M, Chiu YH, Lohman AW, et al. A molecular signature in the pannexin1 intracellular loop confers channel activation by the α1 adrenoreceptor in smooth muscle cells[J]. Sci Signal, 2015, 8(364): ra17.
[8] 郑翔, 叶升, 赵伟, 等. Pannexin1离子通道的结构与功能研究进展[J]. 生物化学与生物物理进展, 2021, 48(10): 1137-1145.
[9] Crespo YS, Willebrords J, Johnstone SR, et al. Pannexin1 as mediator of inflammation and cell death[J]. Biochim Biophys Acta Mol Cell Res, 2017, 1864(1): 51-61.
[10] Graham SV, Jiang JX, Mesnil M. Connexins and Pannexins: Important players in tumorigenesis, metastasis and potential therapeutics[J]. Int J Mol Sci, 2018, 19(6): 1645-1672.
[11] Whyte-Fagundes P, Zoidl G. Mechanisms of pannexin1 channel gating and regulation[J]. Biochim Biophys Acta Biomembr, 2018, 1860(1): 65-71.
[12] Young CN, Brutkowski W, Lien CF, et al. P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment[J]. J Cell Mol Med, 2012, 16(5): 1026-1037.
[13] Xiao J, Yang R, Qin X, et al. A role of AMPK and connexin 43 in the suppression of CoCl2-induced apoptosis of spiral modiolar artery smooth muscle cells by adiponectin[J]. Life Sci, 2019, 238: 116876.
[14] Tian X, Sun C, Wang X, et al. ANO1 regulates cardiac fibrosis via ATI-mediated MAPKpathway[J]. Cell Calcium, 2020, 92: 102306.
[15] Cao N, Tang X, Gao R, et al. Galectin-3 participates in PASMC migration and proliferation by interacting with TGF-β1[J]. Life Sci, 2021, 274: 119347.
[16] Zhu N, Xiang YJ, Zhao XY, et al. Thymoquinone suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation, migration and neointimal formation[J]. J Cell Mol Med, 2019, 23(12): 8482-8492.
[17] Neijssen J, Herberts C, Drijfhout JW, et al. Cross-presentation by intercellular peptide transfer through gap junctions[J]. Nature, 2005, 434(7029): 83-88.
[18] Grimmer B, Krauszman A, Hu X, et al. Pannexin 1-a novel regulator of acute hypoxic pulmonary vasoconstriction[J]. Cardiovasc Res, 2021,118(11): 2535-2547.
[19] Freeman TJ, Sayedyahossein S, Johnston D, et al. Inhibition of Pannexin 1 reduces the tumorigenic properties of human melanoma Cells[J]. Cancers (Basel), 2019, 11(1): 102-126.
[20] Furlow PW, Zhang S, Soong TD, et al. Mechanosensitive pannexin-1 channels mediate microvascular metastatic cell survival[J]. Nat Cell Biol, 2015, 17(7): 943-949.
[21] Liu HF, Yuan M, Yao YX, et al. In vitro effect of Pannexin 1 channel on the invasion and migration of I-10 testicular cancer cells via ERK1/2 signaling pathway[J]. Biomed Pharmacother, 2019, 117: 109090.
[22] 邹呈雨, 宋关斌. 骨桥蛋白促细胞迁移作用及其分子机理[J]. 生命的化学, 2009, 29(04): 543-546.
[23] 宋楠萌, 桑建利, 徐恒. 增殖细胞核抗原(PCNA)的分子结构及其生物学功能研究进展[J]. 自然科学进展, 2006, 10(1): 1201-1209.
[24] Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammaliancells[J]. Int J Biochem Cell Biol, 2008, 40(12): 2707-2719.
[25] Peng LQ, Chen YW, Li Y, et al. Chemerin regulates the proliferation and migration of pulmonary arterial smooth muscle cells via the ERK1/2 signaling pathway[J] . Front Pharmacol, 2022, 13: 767705.